Gemcitabine: single-agent and combination therapy in non-small cell lung cancer.

Gemcitabine: single-agent and combination therapy in non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q33679980
Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspectiveA phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumorsClinical effectiveness and clinical toxicity associated with platinum-based doublets in the first-line setting for advanced non-squamous non-small cell lung cancer in Chinese patients: a retrospective cohort study.Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma.Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells.Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer.CyclinD1 protein plays different roles in modulating chemoresponses in MCF7 and MDA-MB231 cellsA phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer.Encapsulating a Hydrophilic Chemotherapeutic into Rod-like Nanoparticles of a Genetically Encoded Asymmetric Triblock Polypeptide Improves its Efficacy
P2860

Gemcitabine: single-agent and combination therapy in non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q33679980
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Gemcitabine: single-agent and combination therapy in non-small cell lung cancer.
@ast
Gemcitabine: single-agent and combination therapy in non-small cell lung cancer.
@en
type
label
Gemcitabine: single-agent and combination therapy in non-small cell lung cancer.
@ast
Gemcitabine: single-agent and combination therapy in non-small cell lung cancer.
@en
prefLabel
Gemcitabine: single-agent and combination therapy in non-small cell lung cancer.
@ast
Gemcitabine: single-agent and combination therapy in non-small cell lung cancer.
@en
P1433
P1476
P2093
P304
P31
P433
P478
P577
P698
P1433
P1476
Gemcitabine: single-agent and combination therapy in non-small cell lung cancer.
@en
P2093
P304
P31
P433
P478
P577
P698